Could fewer radiation sessions after surgery improve quality of life for head and neck cancer patients?
NCT ID NCT04403620
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a shorter, more intense course of radiation therapy (hypofractionated IMRT) given after surgery for head and neck cancer. The goal is to see if it is safe and if it can help patients maintain better swallowing function compared to the standard longer radiation schedule. About 59 adults with certain types of head and neck cancer are being enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Intensity-modulated radiation therapy (IMRT)
- What this could lead to
- If successful, this could offer a shorter, more convenient radiation schedule after surgery that preserves swallowing function better than standard treatment.
- What could go wrong
- This is an early-phase trial with only 59 participants, so results may not apply to all patients. Higher radiation doses could increase side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smartphone app aims to combat malnutrition in head and neck cancer patients
- Can adding radiation boost immunotherapy against spread head and neck cancer?
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Mouth rinse could ease painful radiation side effects for head and neck cancer patients
- New drug aims to spare cancer patients from debilitating mouth sores
- New lozenge aims to ease radiation mouth sores for hours